Literature DB >> 31390168

Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis.

Peter A Nigrovic1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31390168      PMCID： PMC6817387          DOI： 10.1002/art.41071

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  17 in total

1.  Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.

Authors:  Peter A Nigrovic; Melissa Mannion; Femke H M Prince; Andrew Zeft; C Egla Rabinovich; Marion A J van Rossum; Elisabetta Cortis; Manuela Pardeo; Paivi M Miettunen; Ginger Janow; James Birmingham; Aaron Eggebeen; Erin Janssen; Andrew I Shulman; Mary Beth Son; Sandy Hong; Karla Jones; Norman T Ilowite; Randy Q Cron; Gloria C Higgins
Journal:  Arthritis Rheum       Date:  2011-02

2.  T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung.

Authors:  Shoichi Iriguchi; Norihiro Kikuchi; Shin Kaneko; Emiko Noguchi; Yuko Morishima; Masashi Matsuyama; Keigyou Yoh; Satoru Takahashi; Hiromitsu Nakauchi; Yukio Ishii
Journal:  Blood       Date:  2014-10-27       Impact factor: 22.113

Review 3.  Interleukin-18 in pediatric rheumatic diseases.

Authors:  Giusi Prencipe; Claudia Bracaglia; Fabrizio De Benedetti
Journal:  Curr Opin Rheumatol       Date:  2019-09       Impact factor: 5.006

4.  Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles.

Authors:  Masaki Shimizu; Yasuo Nakagishi; Akihiro Yachie
Journal:  Cytokine       Date:  2012-12-29       Impact factor: 3.861

5.  Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome.

Authors:  Ricardo A G Russo; María M Katsicas
Journal:  J Rheumatol       Date:  2013-01-15       Impact factor: 4.666

6.  Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Authors:  Claudia Bracaglia; Kathy de Graaf; Denise Pires Marafon; Florence Guilhot; Walter Ferlin; Giusi Prencipe; Ivan Caiello; Sergio Davì; Grant Schulert; Angelo Ravelli; Alexei A Grom; Cristina de Min; Fabrizio De Benedetti
Journal:  Ann Rheum Dis       Date:  2016-06-13       Impact factor: 19.103

7.  Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.

Authors:  Yukiko Kimura; Jennifer E Weiss; Kathryn L Haroldson; Tzielan Lee; Marilynn Punaro; Sheila Oliveira; Egla Rabinovich; Meredith Riebschleger; Jordi Antón; Peter R Blier; Valeria Gerloni; Melissa M Hazen; Elizabeth Kessler; Karen Onel; Murray H Passo; Robert M Rennebohm; Carol A Wallace; Patricia Woo; Nico Wulffraat
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

8.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.

Authors:  Virginia Pascual; Florence Allantaz; Edsel Arce; Marilynn Punaro; Jacques Banchereau
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

9.  Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study.

Authors:  Nienke M Ter Haar; E H Pieter van Dijkhuizen; Joost F Swart; Annet van Royen-Kerkhof; Ayman El Idrissi; Arjen P Leek; Wilco de Jager; Mark C H de Groot; Saskia Haitjema; Dirk Holzinger; Dirk Foell; Jorg van Loosdregt; Nico M Wulffraat; Sytze de Roock; Sebastiaan J Vastert
Journal:  Arthritis Rheumatol       Date:  2019-05-25       Impact factor: 10.995

Review 10.  Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.

Authors:  Katrin D Mayer-Barber; Bo Yan
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530
View more
  2 in total

Review 1.  The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis.

Authors:  Bryce A Binstadt; Peter A Nigrovic
Journal:  Arthritis Rheumatol       Date:  2022-05-29       Impact factor: 15.483

Review 2.  Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18.

Authors:  Sara Alehashemi; Raphaela Goldbach-Mansky
Journal:  Front Immunol       Date:  2020-08-25       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.